Literature DB >> 26408664

IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.

Anneli Peters1, Kevin D Fowler1, Fanny Chalmin2, Doron Merkler3, Vijay K Kuchroo4, Caroline Pot5.   

Abstract

It is known that differentiation of Th17 cells is promoted by activation of STAT3 and inhibited by activation of STAT1. Although both transcription factors are activated by several cytokines, including IL-6, IL-21, and IL-27, each of these cytokines has a very different effect on Th17 differentiation, ranging from strong induction (IL-6) to strong inhibition (IL-27). To determine the molecular basis for these differences, we measured STAT3 and STAT1 activation profiles for IL-6, IL-21, and IL-27, as well as for cytokine pairs over time. We found that the ratio of activated STAT3/activated STAT1 is crucial in determining whether cytokines promote or inhibit Th17 differentiation. IL-6 and IL-21 induced p-STAT3/p-STAT1 ratios > 1, leading to the promotion of Th17 differentiation, whereas IL-27 or IL-6+IL-27 induced p-STAT3/p-STAT1 ratios < 1, resulting in inhibition of Th17 differentiation. Consistent with these findings, we show that IL-27 induces sufficient p-STAT3 to promote Th17 differentiation in the absence of STAT1. Furthermore, IL-27-induced STAT1-deficient T cells were indistinguishable from bona fide highly proinflammatory Th17 cells because they induced severe experimental autoimmune encephalomyelitis upon adoptive transfer. Our results suggest that the ratio of p-STAT3/p-STAT1 induced by a cytokine or cytokine pairs can be used to predict whether they induce a competent Th17-differentiation program.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408664      PMCID: PMC4610870          DOI: 10.4049/jimmunol.1302246

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  General nature of the STAT3-activated anti-inflammatory response.

Authors:  Karim C El Kasmi; Jeff Holst; Maryaline Coffre; Lisa Mielke; Antoine de Pauw; Nouara Lhocine; Amber M Smith; Robert Rutschman; Deepak Kaushal; Yuhong Shen; Takashi Suda; Raymond P Donnelly; Martin G Myers; Warren Alexander; Dario A A Vignali; Stephanie S Watowich; Matthias Ernst; Douglas J Hilton; Peter J Murray
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.

Authors:  Xuexian O Yang; Athanasia D Panopoulos; Roza Nurieva; Seon Hee Chang; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

4.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.

Authors:  Heon Park; Zhaoxia Li; Xuexian O Yang; Seon Hee Chang; Roza Nurieva; Yi-Hong Wang; Ying Wang; Leroy Hood; Zhou Zhu; Qiang Tian; Chen Dong
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

5.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

6.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

7.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

Review 8.  The JAK-STAT signaling pathway: input and output integration.

Authors:  Peter J Murray
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

9.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

10.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

View more
  25 in total

1.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

2.  The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs.

Authors:  Aditya Arra; Holger Lingel; Benno Kuropka; Jonas Pick; Tina Schnoeder; Thomas Fischer; Christian Freund; Mandy Pierau; Monika C Brunner-Weinzierl
Journal:  Oncoimmunology       Date:  2017-01-20       Impact factor: 8.110

Review 3.  The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Authors:  Xiaodan Zheng; Yuhai Hu; Chengfang Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

4.  Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein Response.

Authors:  Vivian Lei; Chelsea Handfield; Jeffery T Kwock; Stephen J Kirchner; Min Jin Lee; Margaret Coates; Kaiyuan Wang; Qingjian Han; Zilong Wang; Jennifer G Powers; Sarah Wolfe; David L Corcoran; Brian Fanelli; Manoj Dadlani; Ru-Rong Ji; Jennifer Y Zhang; Amanda S MacLeod
Journal:  J Invest Dermatol       Date:  2022-01-07       Impact factor: 7.590

5.  Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells.

Authors:  Rodolfo Thomé; Jason N Moore; Elisabeth R Mari; Javad Rasouli; Daniel Hwang; Satoshi Yoshimura; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad M Rostami
Journal:  Front Immunol       Date:  2017-10-27       Impact factor: 7.561

6.  Lower level of IL‑35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test‑positive hemocytopenia.

Authors:  Yi Li; Yihao Wang; Hui Liu; Kai Ding; Shanfeng Hao; Yuanyuan Shao; Honglei Wang; Jin Chen; Lei Huang; Zonghong Shao; Rong Fu
Journal:  Mol Med Rep       Date:  2017-12-11       Impact factor: 2.952

7.  Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.

Authors:  Patrice H Lalive; Mario Kreutzfeldt; Odile Devergne; Imke Metz; Wolfgang Bruck; Doron Merkler; Caroline Pot
Journal:  J Neuroinflammation       Date:  2017-07-24       Impact factor: 8.322

8.  STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade.

Authors:  Sanjay Varikuti; Steve Oghumu; Mohamad Elbaz; Greta Volpedo; Dinesh K Ahirwar; Pablo C Alarcon; Rachel H Sperling; Ellen Moretti; Marissa S Pioso; Jennifer Kimble; Mohd W Nasser; Ramesh K Ganju; Cesar Terrazas; Abhay R Satoskar
Journal:  Oncoimmunology       Date:  2017-08-14       Impact factor: 8.110

9.  Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.

Authors:  Fangchen Gong; Jin Wu; Ping Zhou; Mengyao Zhang; Jingning Liu; Ying Liu; Xiang Lu; Zhengxia Liu
Journal:  Mediators Inflamm       Date:  2016-10-18       Impact factor: 4.711

10.  IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.

Authors:  Solenne Vigne; Fanny Chalmin; Donovan Duc; Aurélie S Clottu; Lionel Apetoh; Jean-Marc A Lobaccaro; Isabelle Christen; Juan Zhang; Caroline Pot
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.